Importantly, the decreased tumor growth was associated with antagonist-induced decreases in p-Akt levels and COX-2 expression suggesting, together with the data presented herein, that GRPR blockage may be an effective means of decreasing COX-2 expression within receptor-positive tumor tissue. This evidence concerns the gene PTGS2 and neoplasm.